Takeda seeks acquisition opportunities in Brazil
A Takeda está buscando oportunidades de aquisições no Brasil
Intel ID : 237346
| Synopsis |
|
Takeda, a Japanese pharmaceutical company, is looking for acquisition opportunities in Brazil tied to the sector, as published by newspaper Valor Econômico on 3 June 2016, citing its president for Latin America, Ricardo Marek. According to the news, a potential acquisition should be tied to strategic therapeutic segments for the company, which would complement its portfolio. The acquisition could also include Over-the-Counter drugs segment, which would imply a large number of laboratories in Brazil. "Brazil is a vital country for the company's growth. We are active in mergers and acquisitions," said Ricardo Marek.
(content in portuguese)
A Takeda, farmacêutica japonesa, está buscando oportunidades de aquisições de outras farmacêuticas no Brasil, segundo publicou o Valor Econômico no dia 03 de junho de 2016, citando o Presidente do laboratório no país e na América Latina, Ricardo Marek. Segundo a notícia, uma provável aquisição tende a levar em conta as áreas terapêuticas estratégicas para a multinacional, em complementação a seu portfólio, e o mercado de OTC (medicamentos isentos de prescrição), que concentra um grande número de laboratórios nacionais. "O Brasil é um país vital para o crescimento da organização. Estamos ativos em fusões e aquisições", disse Ricardo Marek. |
| Intel ID | 237346 | |
| Value | ND | |
| Native Currency |
Brazilian Real (BRL)
Exchange Rate:  |
|
| Date |
 |
|
| Country | |
|
| Region | ||
| Continent | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.